NASDAQ:SNNA Sienna Biopharmaceuticals (SNNA) Stock Price, News & Analysis → Do This Before July 30 2024 To Claim Trump’s Gift (From Wealthpin Pro) (Ad) Free SNNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.11▼$0.1750-Day Range$0.14▼$0.1452-Week Range$0.06▼$3.80Volume13.32 million shsAverage Volume1.87 million shsMarket Capitalization$4.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Sienna Biopharmaceuticals alerts: Email Address Ad Porter & CompanyThe only financial event in 2024 that matters Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here About Sienna Biopharmaceuticals Stock (NASDAQ:SNNA)Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.Read More Ad Porter & CompanyThe only financial event in 2024 that matters Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here SNNA Stock News HeadlinesMay 28, 2024 | msn.comSienna Miller and Beau Oli Green Enjoy a Pal’s Wedding in the Picturesque Venice, Italy! | Sienna Miller, Oli Green | Just Jared: Celebrity GossipMay 28, 2024 | msn.comHollyoaks spoiler: Sienna discovers Martha's identityMay 28, 2024 | msn.comHollyoaks' Sienna to discover Martha's identity after drugging plotMay 27, 2024 | msn.comHollyoaks confirms drugging story for Sienna - as she's spiked by someone closeMay 26, 2024 | msn.comSienna Miller’s Rare Comments About Jude Law Reveal How Dating Him Turned ‘Dark So Quickly'May 25, 2024 | msn.comSienna Miller: I’m lucky to be here after love for Jude turned me into a ‘piece of prey’May 24, 2024 | msn.comSienna Miller Discusses the Impact of Public Scrutiny on Her Past Relationship with Jude LawMay 24, 2024 | msn.comSienna Miller reflects on ‘madness and chaos’ of Jude Law relationshipMay 24, 2024 | yahoo.comSienna Miller Was ‘Madly in Love’ With Jude Law But Their Romance Got ‘Dark’ Quickly: ‘Chaos’May 24, 2024 | msn.comSienna Miller Admits Jude Law Romance 'Quickly' Turned Into 'Chaos and Madness'May 24, 2024 | msn.comSienna Miller Is 'Proud' of How She Bounced Back After 'Chaos' Surrounding Jude Law RelationshipMay 24, 2024 | ca.style.yahoo.comSienna Miller's Hair Stylist Explains How To Achieve Her 'Ethereal And Effortless' HairMay 24, 2024 | msn.comSienna Miller Recalls 'Chaos' Surrounding Her Public Romance With Jude LawMay 23, 2024 | juniorminingnetwork.comSienna Acquires the "Case Lake West Cesium and Spodumene Pegmatite Project" in OntarioMay 23, 2024 | msn.comSienna buys Case Lake West Cesium and Spodumene Pegmatite projectMay 23, 2024 | msn.comSienna Miller Is The Ultimate Female Power PlayerMay 22, 2024 | msn.comPrincess Beatrice gives hint at sweet bedtime ritual with daughter Sienna as she pays surprise visit to schoolchildrenMay 22, 2024 | msn.comRare family moments at Cannes Film Festival: Sienna Miller's daughter, Richard Gere's son, moreMay 21, 2024 | yahoo.comSienna Miller’s Daughter Marlowe Appears on Cannes' Red CarpetMay 21, 2024 | msn.comHollyoaks confirms arrest twist for Sienna Blake as much-loved resident is brutally attackedMay 21, 2024 | msn.com2024 Toyota Sienna: A Trim ComparisonMay 20, 2024 | msn.comBarrel Jeans Just Got The Sienna Miller Treatment At The Cannes Film FestivalMay 20, 2024 | msn.comInside the ultra-luxe Maldivian hotel where Sienna Miller babymooned: $3K-per-night villa, tree houses, hypnobirthing classesMay 20, 2024 | msn.comSienna Miller and Daughter Marlowe Have Sweet Red-Carpet Moment in CannesMay 20, 2024 | msn.comSienna Miller's Daughter Marlowe Sturridge Makes Cannes Red Carpet Debut for ‘Horizon' Premiere in Complementary Whimsical LookSee More Headlines Receive SNNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sienna Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2019Today6/01/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:SNNA CUSIPN/A CIK1656328 Webwww.siennabio.com Phone(818) 629-2256FaxN/AEmployees39Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,470,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-177.36% Return on Assets-52.22% Debt Debt-to-Equity RatioN/A Current Ratio15.27 Quick Ratio15.27 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.27 per share Price / Book0.11Miscellaneous Outstanding Shares30,908,000Free FloatN/AMarket Cap$4.20 million OptionableNot Optionable Beta2.67 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesFrederick C. BeddingfieldPresident, Chief Executive Officer & DirectorMajed KheirVice President-OperationsPaul F. LizzulChief Medical OfficerSilvio TraversaChief Scientific OfficerTodd J. HarrisDirector & Head-Corporate DevelopmentKey CompetitorsMinerva NeurosciencesNASDAQ:NERVTonix PharmaceuticalsNASDAQ:TNXPOrgenesisNASDAQ:ORGSTraws PharmaNASDAQ:TRAWNeuroSense TherapeuticsNASDAQ:NRSNView All Competitors SNNA Stock Analysis - Frequently Asked Questions How were Sienna Biopharmaceuticals' earnings last quarter? Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) announced its quarterly earnings results on Thursday, March, 14th. The company reported ($0.93) EPS for the quarter, missing analysts' consensus estimates of ($0.83) by $0.10. What other stocks do shareholders of Sienna Biopharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sienna Biopharmaceuticals investors own include SCYNEXIS (SCYX), Allena Pharmaceuticals (ALNA), Spectrum Pharmaceuticals (SPPI), Selecta Biosciences (SELB), Viking Therapeutics (VKTX), Novavax (NVAX), Synergy Pharmaceuticals (SGYP), Zealand Pharma A/S (ZEAL) and Bausch Health Companies (BHC). When did Sienna Biopharmaceuticals IPO? Sienna Biopharmaceuticals (SNNA) raised $64 million in an IPO on Thursday, July 27th 2017. The company issued 4,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Cowen and BMO Capital Markets served as the underwriters for the IPO. This page (NASDAQ:SNNA) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sienna Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.